Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,710 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

NCT07354074

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Medical Center New York Presbyterian New York, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
  • Novartis Investigative Site Brisbane, Queensland, Australia
View all 30 locations
View Trial Details
Recruiting

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

NCT07249346

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

NCT07586618

Conditions
Acute Lymphoblastic Leukemia ALL, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT05237986

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children s Hospital of Los Angeles Los Angeles, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Seattle Children s Hospital Seattle, Washington, United States
View Trial Details
Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

NCT07284433

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Evanston, Illinois, United States
  • Brown University Health Providence, Rhode Island, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 13 locations
View Trial Details
Recruiting

CIML NK Cells With Venetoclax for AML

NCT06152809

Conditions
Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Hematologic Diseases, +6 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

NCT05495035

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • Department of Hematology/Oncology, Shanghai Jiaotong University School of Medicine Affiliated Shanghai Children's Medical Center Shanghai, China
View Trial Details

Related conditions